Gene Symbol | RPS6KA2 |
Entrez ID | 6196 |
Uniprot ID | Q15349 |
Description | ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
Chromosomal Location | chr6: 166,409,364-166,906,451 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001556 |
oocyte maturation |
A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization. |
IEA |
BP |
GO:0002035 |
brain renin-angiotensin system |
The process in which an angiotensin-mediated signaling system present in the brain regulates the force with which blood passes through the circulatory system. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
NAS |
BP |
GO:0007507 |
heart development |
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
IEA |
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
IDA |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEA |
BP |
GO:0010659 |
cardiac muscle cell apoptotic process |
A form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases, whose actions dismantle a cardiac muscle cell and result in its death. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. |
IEA |
BP |
GO:0018105 |
peptidyl-serine phosphorylation |
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. |
IEA |
BP |
GO:0035556 |
intracellular signal transduction |
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
IEA |
BP |
GO:0043065 |
positive regulation of apoptotic process |
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
IDA |
BP |
GO:0045786 |
negative regulation of cell cycle |
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
IDA |
BP |
GO:0045835 |
negative regulation of meiotic nuclear division |
Any process that stops, prevents, or reduces the frequency, rate or extent of meiosis. |
IEA |
BP |
GO:0060047 |
heart contraction |
The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body. |
IEA |
BP |
GO:0070613 |
regulation of protein processing |
Any process that modulates the frequency, rate or extent of protein processing, any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. |
IEA |
BP |
GO:0071322 |
cellular response to carbohydrate stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus. |
IEA |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
IDA|TAS |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005819 |
spindle |
The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. |
IEA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
TAS |
CC |
GO:0031965 |
nuclear membrane |
Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
IDA |
MF |
GO:0000287 |
magnesium ion binding |
Interacting selectively and non-covalently with magnesium (Mg) ions. |
IEA |
MF |
GO:0004674 |
protein serine/threonine kinase activity |
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
TAS |
MF |
GO:0004711 |
ribosomal protein S6 kinase activity |
Catalysis of the reaction: ribosomal protein S6 + ATP = ribosomal protein S6 phosphate + ATP. |
IEA |
MF |
GO:0004712 |
protein serine/threonine/tyrosine kinase activity |
Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
IDA |
MF |
GO:0005524 |
ATP binding |
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
IEA |
MF |
GO:0016301 |
kinase activity |
Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
TAS |
Domain ID | Description |
---|---|
IPR000719 |
Protein kinase domain |
IPR000961 |
AGC-kinase, C-terminal |
IPR008271 |
Serine/threonine-protein kinase, active site |
IPR011009 |
Protein kinase-like domain |
IPR016239 |
Ribosomal protein S6 kinase II |
IPR017441 |
Protein kinase, ATP binding site |
IPR017892 |
Protein kinase, C-terminal |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04010 |
MAPK signaling pathway |
KEGG |
hsa04114 |
Oocyte meiosis |
KEGG |
hsa04150 |
mTOR signaling pathway |
KEGG |
hsa04720 |
Long-term potentiation |
KEGG |
hsa04722 |
Neurotrophin signaling pathway |
KEGG |
hsa04914 |
Progesterone-mediated oocyte maturation |
KEGG |
hsa04931 |
Insulin resistance |
KEGG |
WP437 |
EGF/EGFR Signaling Pathway |
WikiPathways |
WP3915 |
Angiopoietin Like Protein 8 Regulatory Pathway |
WikiPathways |
WP481 |
Insulin Signaling |
WikiPathways |
WP477 |
Cytoplasmic Ribosomal Proteins |
WikiPathways |
WP2037 |
Prolactin Signaling Pathway |
WikiPathways |
h_mapkPathway |
MAPKinase Signaling Pathway |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0011334 |
Dental Caries |
C1272641 |
Systemic Arterial Pressure |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15291743 |
Diao et al. |
2004 |
The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray |
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
RPS6KA3 |
6197 |
P51812 |
0.00 |
RPS6KA4 |
8986 |
O75676 |
0.00 |
RPS6KA6 |
27330 |
Q9UK32 |
0.00 |
NQO2 |
4835 |
P16083 |
0.49 |
STXBP2 |
6813 |
Q15833 |
0.49 |
FOS |
2353 |
P01100 |
0.52 |
JUN |
3725 |
P05412 |
0.52 |
MAP2K1 |
5604 |
Q02750 |
0.52 |
L1CAM |
3897 |
P32004 |
0.55 |
FLNC |
2318 |
Q14315 |
0.63 |
PRKCA |
5578 |
P17252 |
0.63 |
RPS6KA2 |
6196 |
Q15349 |
0.65 |
BAD |
572 |
Q92934 |
0.66 |
CREB1 |
1385 |
P16220 |
0.66 |
PKM |
5315 |
P14618 |
0.68 |
RPS6 |
6194 |
P62753 |
0.68 |
FAT1 |
2195 |
Q14517 |
0.72 |
GRSF1 |
2926 |
Q12849 |
0.72 |
SHROOM3 |
57619 |
Q8TF72 |
0.72 |
MAPK1 |
5594 |
P28482 |
0.96 |
BUB1 |
699 |
O43683 |
0.00 |
IGF1 |
3479 |
P05019 |
0.00 |
KRAS |
3845 |
P01116 |
0.00 |
PKMYT1 |
9088 |
Q99640 |
0.00 |
HSP90AB1 |
3326 |
P08238 |
0.49 |
SYK |
6850 |
P43405 |
0.49 |
BRAF |
673 |
P15056 |
0.63 |
CSNK2B |
1460 |
P67870 |
0.63 |
HSP90AA1 |
3320 |
P07900 |
0.63 |
PRKCE |
5581 |
Q02156 |
0.63 |
ZMYM5 |
9205 |
Q9UJ78 |
0.63 |
MAGI1 |
9223 |
Q96QZ7 |
0.63 |
ECE2 |
9718 |
O60344 |
0.63 |
CREBBP |
1387 |
Q92793 |
0.72 |
RPS6KA1 |
6195 |
Q15418 |
0.72 |
SHANK1 |
50944 |
Q9Y566 |
0.72 |
MAPK3 |
5595 |
P27361 |
0.95 |